A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Clinical trial NCT07114601 · RECRUITING

Trial details

NCT number: NCT07114601
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Neoplasms Colorectal Neoplasms Prostate Neoplasm Endometrial Neoplasms Neoplasm Metastasis Stomach Neoplasms Esophageal Neoplasms

Start date: 2025-08-06
Primary completion: 2030-04-01
Enrollment: 421

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.